← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Va New York Harbor Hlthcare/Sys/Brooklyn
Brooklyn, NY
$0
Total funding
12
Grants
Funding over time
peak $0 · FY2012–25$1$1$1$0$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 12
By mechanism
I01$0 · 10
I21$0 · 2
Investigators at Va New York Harbor Hlthcare/Sys/Brooklyn
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2014 · VA
Regulation of plasma lipids and atherosclerosis by miR-30c$0
I01 · FY2014 · VA
A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging$0
I01 · FY2021 · VA
Regulation of plasma lipids and atherosclerosis by miR-30c$0
I01 · FY2015 · VA
Genetic Regulation of Metabolic and Fibrotic Programs in Hypertrophic Heart$0
I01 · FY2015 · VA
Genetic Regulation of Metabolic and Fibrotic Programs in Hypertrophic Heart$0
I01 · FY2016 · VA
Regulation of plasma lipids and atherosclerosis by miR-30c$0
I01 · FY2016 · VA
Genetic Regulation of Metabolic and Fibrotic Programs in Hypertrophic Heart$0
I01 · FY2014 · VA
Regulation of plasma lipids and atherosclerosis by miR-30c$0
I01 · FY2013 · VA
Genetic Regulation of Metabolic and Fibrotic Programs in Hypertrophic Heart$0
I01 · FY2013 · VA
Autoimmune Associated Novel Form of Acquired Long QT Syndrome$0
I01 · FY2016 · VA
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2015 · VA
NOVEL MECHANISMS AND THERAPEUTIC APPROACHES TO IMMUNO-INFLAMMATORY LONG OT SYNDROME$0
I01 · FY2021 · VA
MicroRNAs regulating plasma LDL and HDL$0
I01 · FY2021 · VA
Autoimmune Associated Novel Form of Acquired Long QT Syndrome$0
I01 · FY2015 · VA
Molecular and Genetic Studies of Bladder Tumorigenesis$0
I01 · FY2015 · VA
Mechanisms and Therapeutic Role of C-terminus of Cav1.3 L-type Calcium Channel in the Heart$0
I01 · FY2023 · VA
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2013 · VA
Effect of SMSr on VLDL metabolism and atherosclerosis$0
I01 · FY2022 · VA
Tissue plasminogen activator for the treatment of glaucoma$0
I01 · FY2023 · VA